Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
EpimAb Biotherapeutics Appoints Yonghong Zhu, M.D., Ph.D., as Chief Medical Officer
EpimAb Biotherapeutics, a clinical-stage biotechnology company specializing in the development of bispecific antibodies, today announced […]
RenovoRx Appoints Former Chief Medical Officer of Schering-Plough, Robert J. Spiegel, MD, FACP, to Board of Directors
RenovoRx, a biopharmaceutical company focused on targeted drug-delivery with an initial application in locally advanced […]
Legend Biotech Announces Appointment of Chief Medical Officer
Legend Biotech, a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening […]
Rocket Pharmaceuticals Announces Leadership Expansion to Support Company on Evolution Towards Commercial Stage
Rocket Pharmaceuticals, a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic […]
BioSenic Appoints Lieven Huysse, MD, as Chief Medical Officer (CMO)
BioSenic, the company specializing in serious autoimmune and inflammatory diseases and cell repair, today announces […]
Ascidian Therapeutics Appoints Jay A. Barth, M.D., as Chief Medical Officer
Ascidian Therapeutics, a biotechnology company focused on treating human diseases by rewriting RNA, announced today […]
CLEARA Biotech Appoints Nicholas J. Sarlis, MD, PhD as Chief Medical Officer and Head of Clinical Development
CLEARA Biotech, a preclinical-stage biotechnology company focused on developing innovative, proprietary therapies for treating different […]
Medivir Announces Pia Baumann as Chief Medical Officer (CMO)
Medivir AB, a pharmaceutical company focused on developing innovative treatments for cancer in areas of […]
Abivax appoints Dr. Sheldon Sloan, M.D., as Chief Medical Officer
Abivax SA, a Phase 3 clinical-stage biotechnology company focused on developing therapeutics that modulate the […]
Avita Care Solutions Names Dr. Christopher Hall First Chief Medical Officer
Avita Care Solutions, a national healthcare services organization committed to providing comprehensive, compassionate, and inclusive […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more